Description
THIS BILATERAL MODIFICATION LOWERS THE PRICE FOR NDC 16714-0485-02, DIVALPROEX NA SA 500MG TABLETS IN 500-COUNT BOTTLES FOR CONTRACT OPTION YEARS 2, 3, AND 4.
Base award description: NEW AWARD FOR DIVALPROEX NA SA TABLETS WITH MCKESSON CORPORATION DBA SKY PACKAGING. PERIOD OF PERFORMANCE IS AUGUST 18, 2024 TO AUGUST 17, 2025 WITH FOUR ONE-YEAR OPTIONS.
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-06-05+$0= $0
- Mod P000012025-06-02+$0= $0
- Mod P000022025-07-07+$0= $0
- Mod P000032026-01-13+$0= $0
- Mod P000042026-04-07+$0= $0
- Mod P000052026-04-23+$0= $0
- Mod P000072026-06-23+$0= $0
- Mod P000062026-07-06+$0= $0
- Mod P000082026-07-14+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-06-05 | +$0 | $0 | NEW AWARD FOR DIVALPROEX NA SA TABLETS WITH MCKESSON CORPORATION DBA SKY PACKAGING. PERIOD OF PERFORMANCE IS A… |
| Mod P00001· ADD SUBCONTRACTING PLAN | 2025-06-02 | +$0 | $0 | INCORPORATION OF 2025 SMALL BUSINESS SUBCONTRACTING PLAN FOR MCKESSON CORPORATION DBA SKY PACKAGING. THE PLAN… |
| Mod P00002· EXERCISE AN OPTION | 2025-07-07 | +$0 | $0 | EXERCISE OPTION YEAR 1, EFFECTIVE 08/18/2025 - 08/17/2026, FOR DIVALPROEX SA NA (24HR) TABLETS (36E79724D0028)… |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2026-01-13 | +$0 | $0 | VENDOR REQUEST TO CORRECT TAX IDENTIFICATION NUMBER ON CONTRACT FILE. |
| Mod P00004· ADD SUBCONTRACTING PLAN | 2026-04-07 | +$0 | $0 | INCORPORATION OF 2026 SMALL BUSINESS SUBCONTRACTING PLAN FOR MCKESSON CORPORATION DBA SKY PACKAGING. THE PLAN… |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2026-04-23 | +$0 | $0 | UPDATE SALES REPORT AND AUTHORIZED NEGOTIATOR POINT OF CONTACT (POC) ON CONTRACT FILE. |
| Mod P00007· EXERCISE AN OPTION | 2026-06-23 | +$0 | $0 | EXERCISE OPTION YEAR 2, EFFECTIVE 08/18/2026 - 08/17/2027, FOR DIVALPROEX SA NA (24HR) TABLETS (36E79724D0028)… |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2026-07-06 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE EXECUTIVE ORDER 14398, CLAUSE 52.222-90, INTO THE CONTRACT. |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-07-14 | +$0 | $0 | THIS BILATERAL MODIFICATION LOWERS THE PRICE FOR NDC 16714-0485-02, DIVALPROEX NA SA 500MG TABLETS IN 500-COUN… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VMJLFQE5U511)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24225P1011 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $4,853 | FY2025 |
| 36C24825P0474 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $11,859 | FY2025 |
| 36C25024P1401 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $16,500 | FY2024 |
| 36C25024P0630 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $20,786 | FY2024 |
| 36C25024P0413 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $5,196 | FY2024 |
| 36C24224P0289 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $10,312 | FY2024 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79724D0028_3600 · retrieved 2026-09-26.